Myocarditis is a condition characterized by inflammation of the heart muscle, known as the myocardium. This inflammation is often triggered by a viral infection, but it can also result from bacterial or fungal infections, certain medications, or exposure to toxins. The inflammation weakens the heart muscle, affecting its ability to pump blood efficiently. Symptoms of myocarditis can vary widely, ranging from mild fatigue and chest discomfort to more severe complications, such as heart failure or abnormal heart rhythms. Diagnosing a condition typically requires a comprehensive approach that involves reviewing the patient's medical history, conducting a thorough physical examination, performing blood tests, and utilizing various imaging studies.. While mild cases may resolve on their own, more severe instances may require medical intervention, including medications to reduce inflammation and support heart function. Given its diverse causes and potential complications, early detection and appropriate management are crucial in addressing myocarditis and preventing long-term cardiac issues.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India